Viking Therapeutics (VKTX) Amortizatization of Intangibles (2014 - 2026)

Viking Therapeutics has reported Amortizatization of Intangibles for 10 years, with the latest figure at $885000.0 in Q2 2026.

• Quarterly Amortizatization of Intangibles fell 62.99% year-over-year to $885000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.9 million (down 59.14% YoY) and the FY2025 annual result came in at $9.3 million, down 46.23% from the prior year.
• Amortizatization of Intangibles declined to $885000.0 in Q2 2026 per VKTX's latest filing, from $1.3 million in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $5.4 million in Q2 2024 and troughed at $389000.0 in Q1 2023.
• A 4-year average of $2.6 million and a median of $2.5 million in 2023 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2024 and 2026: Amortizatization of Intangibles surged 625.19% in 2024, then sank 62.99% in 2026.
• Over 4 years, Amortizatization of Intangibles stood at $2.7 million in 2023, then jumped by 49.19% to $4.0 million in 2024, then plunged by 57.06% to $1.7 million in 2025, then tumbled by 48.87% to $885000.0 in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $885000.0, $1.3 million, and $1.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.